Free Trial

Martin Currie Ltd. Invests $13.91 Million in Synopsys, Inc. (NASDAQ:SNPS)

Synopsys logo with Computer and Technology background
Remove Ads

Martin Currie Ltd. purchased a new stake in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 28,664 shares of the semiconductor company's stock, valued at approximately $13,912,000.

A number of other large investors have also recently made changes to their positions in the stock. Kieckhefer Group LLC bought a new position in Synopsys during the fourth quarter valued at approximately $27,000. Whipplewood Advisors LLC bought a new position in shares of Synopsys during the 4th quarter valued at $33,000. Sierra Ocean LLC purchased a new position in shares of Synopsys in the 4th quarter worth $39,000. Newbridge Financial Services Group Inc. bought a new stake in shares of Synopsys in the fourth quarter worth $51,000. Finally, Versant Capital Management Inc increased its position in Synopsys by 109.3% during the fourth quarter. Versant Capital Management Inc now owns 113 shares of the semiconductor company's stock valued at $55,000 after acquiring an additional 59 shares during the last quarter. 85.47% of the stock is currently owned by institutional investors.

Insider Activity

In other news, insider Geus Aart De sold 15,705 shares of the company's stock in a transaction that occurred on Thursday, March 6th. The stock was sold at an average price of $444.42, for a total transaction of $6,979,616.10. Following the transaction, the insider now owns 116,671 shares of the company's stock, valued at approximately $51,850,925.82. This represents a 11.86 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, CRO Richard S. Mahoney sold 20,838 shares of the firm's stock in a transaction that occurred on Wednesday, January 15th. The stock was sold at an average price of $506.01, for a total value of $10,544,236.38. Following the sale, the executive now directly owns 1,460 shares of the company's stock, valued at $738,774.60. This represents a 93.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 47,909 shares of company stock worth $22,794,835. 0.62% of the stock is currently owned by insiders.

Remove Ads

Analyst Upgrades and Downgrades

SNPS has been the subject of a number of recent research reports. Rosenblatt Securities restated a "buy" rating and set a $660.00 price target on shares of Synopsys in a research note on Tuesday, February 25th. Needham & Company LLC reiterated a "buy" rating and set a $650.00 price target on shares of Synopsys in a research note on Thursday, February 27th. Morgan Stanley cut their price objective on shares of Synopsys from $625.00 to $590.00 and set an "overweight" rating for the company in a research report on Monday, February 24th. Redburn Atlantic began coverage on Synopsys in a report on Monday, January 13th. They issued a "buy" rating and a $600.00 target price on the stock. Finally, Robert W. Baird cut their price target on Synopsys from $644.00 to $630.00 and set an "outperform" rating for the company in a report on Thursday, December 5th. One research analyst has rated the stock with a hold rating and eleven have issued a buy rating to the company's stock. According to MarketBeat, Synopsys has a consensus rating of "Moderate Buy" and a consensus target price of $638.58.

Check Out Our Latest Stock Report on Synopsys

Synopsys Stock Up 1.7 %

NASDAQ SNPS traded up $7.09 during trading on Tuesday, hitting $435.94. 985,635 shares of the stock traded hands, compared to its average volume of 1,051,050. Synopsys, Inc. has a 12-month low of $423.08 and a 12-month high of $624.80. The firm has a 50-day simple moving average of $483.67 and a 200-day simple moving average of $505.29. The company has a market capitalization of $67.41 billion, a P/E ratio of 30.02, a price-to-earnings-growth ratio of 3.23 and a beta of 1.16.

Synopsys Profile

(Free Report)

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.

Recommended Stories

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Should You Invest $1,000 in Synopsys Right Now?

Before you consider Synopsys, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.

While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

 5 Stocks to BUY NOW in April 2025
3 Bank Stocks Defying Market Turmoil—Cheap Options Trades!
Time to Buy SoFi? Fintech’s Next Big Move

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads